IDH2 Gene Mutation: Clinical Trials

1 trial for IDH2 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow IDH2 Gene Mutation: new trials by email Literature Review of IDH2 Gene Mutation trials Research Report on IDH2 Gene Mutation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT
Enasidenib - Leukemia, Myeloid, Acute, Myelodysplastic Syndromes
Phase 2CompletedHeinrich-Heine University, Duesseldorf502020-08-272024-09-19

Narrower conditions

Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Myelodysplastic Syndromes (1)

Broader conditions

Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Myelodysplastic-Myeloproliferative Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

enasidenib (1)

Sponsors

Heinrich-Heine University, Duesseldorf (1)

Countries

Germany (1)

Top investigators

Thomas Schroeder, PD Dr. (1)

NIH funding

2019 (1)